We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+21.04%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$179M
AUM Growth
Cap. Flow
+$167M
Cap. Flow %
93.03%
Top 10 Hldgs %
69.33%
Holding
26
New
26
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 65.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLTI
26
DELISTED
QLT Inc
QLTI
$68K 0.04%
+17,000
New +$66.4K

Similar funds

Krensavage Asset Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Krensavage Asset Management, which disclosed 26 positions worth $179M. Its ten largest holdings account for 69% of the portfolio.

Its largest position is United Therapeutics: 124,801 shares worth $16.2M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets.

  • Krensavage Asset Management's largest Q4 2014 buy was United Therapeutics: 124,801 shares worth $16.2M.
  • Krensavage Asset Management's ten largest holdings make up 69% of its $179M portfolio in Q4 2014.
  • Krensavage Asset Management disclosed 26 positions in Q4 2014, its first 13F filing on record.

Based on Krensavage Asset Management's 13F filing for Q4 2014, filed 18 Feb 2015.